These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30977107)

  • 21. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
    Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
    J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple Genomic Alterations, Including a Novel
    Sahin Y; Wang YL; Pei J; Mansoor N; Styler M; Testa JR; Nejati R
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased plasma d-2-hydroxyglutarate in isocitrate dehydrogenase 2-mutated blastic plasmacytoid dendritic cell neoplasm.
    Rakheja D; Fuda F; Vandergriff T; Boriack R; Medeiros BC; Frankel AE; Chen W
    Hum Pathol; 2015 Feb; 46(2):322-6. PubMed ID: 25481493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case report: Blastic plasmacytoid dendritic cell neoplasm is misdiagnosed as breast infiltrating ductal carcinoma.
    Chen KC; Su TC; Chen DR; Liou JH
    Int J Surg Pathol; 2015 Feb; 23(1):84-8. PubMed ID: 25297609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene.
    Stewart W; Traynor JP; Cooke A; Griffiths S; Onen NF; Balsitis M; Shah AA; Upadhyaya M; Tobias ES
    Fam Cancer; 2007; 6(1):147-52. PubMed ID: 16944271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
    Lim MS; Lemmert K; Enjeti A
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
    Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms.
    Small C; Mukerjee S; Jangam D; Gollapudi S; Singh K; Jaye DL; Aung PP; Querfeld C; Yao K; Chisholm KM; Pullarkat S; Wang S; Gru A; Hussaini M; George TI; Ohgami RS
    Int J Lab Hematol; 2023 Oct; 45(5):726-734. PubMed ID: 37282364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blastic plasmacytoid dendritic cell neoplasm.
    Lim D; Goodman H; Rademaker M; Lamont D; Yung A
    Australas J Dermatol; 2013 May; 54(2):e43-5. PubMed ID: 23582004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features.
    Künstner A; Schwarting J; Witte HM; Xing P; Bernard V; Stölting S; Lohneis P; Janke F; Salehi M; Chen X; Kusch K; Sültmann H; Chteinberg E; Fischer A; Siebert R; von Bubnoff N; Merz H; Busch H; Feller AC; Gebauer N
    Leukemia; 2024 May; 38(5):1086-1098. PubMed ID: 38600314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
    Riaz W; Zhang L; Horna P; Sokol L
    Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a missense mutation causing exon skipping in a neurofibromatosis type 1 patient.
    Fu Y; Zhang JQ; Jiang CL; Wang HY
    J Dermatol; 2018 Aug; 45(8):986-988. PubMed ID: 29952103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The NF1 somatic mutational landscape in sporadic human cancers.
    Philpott C; Tovell H; Frayling IM; Cooper DN; Upadhyaya M
    Hum Genomics; 2017 Jun; 11(1):13. PubMed ID: 28637487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
    Angelot-Delettre F; Roggy A; Frankel AE; Lamarthee B; Seilles E; Biichle S; Royer B; Deconinck E; Rowinsky EK; Brooks C; Bardet V; Benet B; Bennani H; Benseddik Z; Debliquis A; Lusina D; Roussel M; Solly F; Ticchioni M; Saas P; Garnache-Ottou F
    Haematologica; 2015 Feb; 100(2):223-30. PubMed ID: 25381130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm.
    Yang N; Huh J; Chung WS; Cho MS; Ryu KH; Chung HS
    Cancer Genet; 2015 Sep; 208(9):464-7. PubMed ID: 26164398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN-Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community.
    Pemmaraju N; Utengen A; Gupta V; Thompson MA; Lane AA
    Curr Hematol Malig Rep; 2018 Dec; 13(6):581-587. PubMed ID: 30338458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm.
    Philippe L; Ceroi A; Bôle-Richard E; Jenvrin A; Biichle S; Perrin S; Limat S; Bonnefoy F; Deconinck E; Saas P; Garnache-Ottou F; Angelot-Delettre F
    Haematologica; 2017 Nov; 102(11):1861-1868. PubMed ID: 28798071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enhancer hijacking via disease-specific chromosomal translocation in blastic plasmacytoid dendritic cell neoplasm].
    Kubota S
    Rinsho Ketsueki; 2020; 61(1):47-51. PubMed ID: 32023603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.
    Stewart DR; Corless CL; Rubin BP; Heinrich MC; Messiaen LM; Kessler LJ; Zhang PJ; Brooks DG
    J Med Genet; 2007 Jan; 44(1):e61. PubMed ID: 17209131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.